Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $131.25 USD
Change Today -0.63 / -0.48%
Volume 3.5M
CELG On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
NASDAQ GM
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. Casey

Independent Lead Director, Chairman of Nominating, Governance & Compliance Committee, Member of Executive Committee and Member of Management Development & Compensation Committee, Celgene Corporation
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 7 different industries.

See Board Relationships
69$859,699

Background*

Mr. Michael D. Casey, also known as Mike, has been a Consultant to the pharmaceutical industry since February 2002. Mr. Casey served as the President and Chief Executive Officer of Matrix Pharmaceutical Inc. from September 1997 to February 2002. He joined Matrix in October 1997 from Schein Pharmaceutical Inc. ("Schein"), a generic and ethical pharmaceutical company. He served as an Executive Vice President of Schein Pharmaceutical Inc. from November 1995 to December ...

Read Full Background

Corporate Headquarters*

86 Morris Avenue
Summit, New Jersey 07901

United States

Phone: 908-673-9000
Fax: --

Board Members Memberships*

2002-Present
Independent Lead Director, Chairman of Nominating, Governance & Compliance Committee, Member of Executive Committee and Member of Management Development & Compensation Committee
2010-Present
Director, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$142,500
Total Calculated Compensation$859,699
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CELG:US $131.25 USD -0.63

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Inc.
$1.4M
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
$500.0K
J. Michael Pearson Chairman and Chief Executive Officer
Valeant Pharmaceuticals International, Inc.
$1.9M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELGENE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.